Key result
Crinum zeylanicum extract lowers blood pressure and heart rate in hypertensive rats.
Why the study?
Crinum zeylanicum leaves extract is traditionally used to treat arterial hypertension and heart problems, but its antihypertensive effects in L-NAME-induced hypertensive rats were not investigated.
Does Crinum zeylanicum extract reduce arterial blood pressure and heart rate in L-NAME-induced hypertensive rats?
Does Crinum zeylanicum extract reduce arterial blood pressure and heart rate in L-NAME-induced hypertensive rats?
p-value: p=<0.001
Crinum zeylanicum extracts demonstrate significant antihypertensive and renal protective effects in a rat model of L-NAME-induced hypertension, supporting its traditional use.
BP reduction in L-NAME rats supports traditional use; leaves open human efficacy and safety.
Arterial hypertension (AHT) is a leading cardiovascular disease, with a high negative impact on the quality of life. Crinum zeylanicum (C. zeylanicum) leaves extract is used in the West region of Cameroon to treat AHT and heart problems. This study aimed to investigate the antihypertensive effect of C. zeylanicum extract in Nω-nitro-L‐arginine methyl ester- (L‐NAME-) induced hypertensive rats. The aqueous extract of C. zeylanicum (LAE) was obtained by lyophilizing the juice of triturated fresh leaves. The methanol extract (LME) prepared by maceration of the dried leaves was further partitioned to chloroform (LCF), ethyl acetate (LEAF), and residual (LRF) fractions. The total polyphenol, flavonoid content, and antiradical potentials of these extracts were determined. The curative antihypertensive and renal function protective effects of LME and LEAF were evaluated in vivo on L-NAME-induced hypertensive rats. Hypertension was induced in rats by oral administration of L-NAME (30 mg/kg/day) for 3 consecutive weeks. Thereafter, plant extracts were administered orally at the doses of 30, 60, and 120 mg/kg/day, concomitantly with L-NAME for three other weeks. Body weight, heart rate, and arterial blood pressure were measured at the end of each week throughout the experimental period. At the end of the treatment, 24-hour urine and plasma were collected to assay nitric oxide (NO), creatinine, and protein. The results revealed that LEAF has the higher content of total polyphenol and flavonoid and exhibited the best antiradical potential. Moreover, treatment of hypertensive rats with LME and LEAF significantly ( p<0.001 ) reduced AHT and heart rate. LME and LEAF significantly increased rat’s body mass, plasmatic NO, and urinary creatinine and reduced urine NO and protein contents as compared to the L-NAME group. LME and its LEAF possess potent antihypertensive effects and further protect the renal function in L-NAME-induced hypertensive rats, thus supporting the use of C. zeylanicum in the management of AHT.
No takes yet. Share an insight, caveat, or question.
Ndjenda et al. (2021) studied Arterial hypertension. Crinum zeylanicum methanol extract (LME) and ethyl acetate fraction (LEAF) vs. L-NAME group was evaluated on Arterial hypertension and heart rate (p=<0.001). Treatment of L-NAME-induced hypertensive rats with Crinum zeylanicum methanol extract and ethyl acetate fraction significantly reduced arterial hypertension and heart rate (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: